Literature DB >> 12557281

The neurobiology, diagnosis, and treatment of narcolepsy.

Thomas E Scammell1.   

Abstract

Narcolepsy is a common cause of chronic sleepiness distinguished by intrusions into wakefulness of physiological aspects of rapid eye movement sleep such as cataplexy and hallucinations. Recent advances provide compelling evidence that narcolepsy may be a neurodegenerative or autoimmune disorder resulting in a loss of hypothalamic neurons containing the neuropeptide orexin (also known as hypocretin). Because orexin promotes wakefulness and inhibits rapid eye movement sleep, its absence may permit inappropriate transitions between wakefulness and sleep. These discoveries have considerably improved our understanding of the neurobiology of sleep and should foster the development of rational treatments for a variety of sleep disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12557281     DOI: 10.1002/ana.10444

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  53 in total

Review 1.  Narcolepsy and excessive daytime sleepiness.

Authors:  Adam Zeman; Tom Britton; Neil Douglas; Andrew Hansen; Jane Hicks; Robin Howard; Andrew Meredith; Ian Smith; Gregory Stores; Sue Wilson; Zenobia Zaiwalla
Journal:  BMJ       Date:  2004-09-25

Review 2.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

3.  Systematic tracking of dysregulated modules identifies disrupted pathways in narcolepsy.

Authors:  Zhenhua Liu; Jiali Zhao; Yinyin Tan; Minglu Tang; Guanzhen Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.

Authors:  Samir Haj-Dahmane; Roh-Yu Shen
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

5.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

6.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

7.  Behavioral state instability in orexin knock-out mice.

Authors:  Takatoshi Mochizuki; Amanda Crocker; Sarah McCormack; Masashi Yanagisawa; Takeshi Sakurai; Thomas E Scammell
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

8.  Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.

Authors:  Fumito Naganuma; Sathyajit S Bandaru; Gianna Absi; Carrie E Mahoney; Thomas E Scammell; Ramalingam Vetrivelan
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

9.  Disrupted Sleep in Narcolepsy: Exploring the Integrity of Galanin Neurons in the Ventrolateral Preoptic Area.

Authors:  Yury V Gavrilov; Brian A Ellison; Mihoko Yamamoto; Hasini Reddy; Johannes Haybaeck; Emmanuel Mignot; Christian R Baumann; Thomas E Scammell; Philipp O Valko
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

10.  Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.

Authors:  Michihiro Mieda; Jon T Willie; Junko Hara; Christopher M Sinton; Takeshi Sakurai; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.